Relonchem

Relonchem is a UK-based pharmaceutical company specializing in the licensing, marketing, and distribution of generic medicinal products. Founded in 2002 and acquired by Marksans Pharma in 2008, the company manages a diverse portfolio of generic drugs across various therapeutic areas, including oncology, cardiovascular, and central nervous system disorders. Relonchem operates as a key subsidiary within Marksans Pharma's European operations, leveraging its regulatory expertise to bring cost-effective treatments to the UK market. The company maintains a robust supply chain and focuses on high-quality manufacturing standards to support healthcare providers and patients. It holds a significant number of Marketing Authorisations (MAs) and serves as a vital link in the UK pharmaceutical supply chain.